 |
|
|
| |
Serum Cholesterol Changes Associated with NGM282 Treatment in Obese Insulin Resistant Cynomolgus Monkeys and NASH Patients are Reversed with Lipid Lowering Agents
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Jian Luo1, Brian Ko1, XunshanDing1, Stephen A. Harrison2, Stephen J. Rossi1, Alex M. DePaoli1and Hui Tian1
1NGM Bio, South San Francisco, CA, USA 2Pinnacle Clinical Research, San Antonio, TX, USA
|
| |
|
|
|
|
|
